Iovance Biotherapeutics, Inc.

Located in the Philadelphia Navy Yard, this 136,000 square-foot facility is home to Iovance Biotherapeutics, Inc., a biotechnology company developing cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology. The combination medical lab and office building allows production according to U.S. Food and Drug Administration (FDA) guidelines and is designed to provide scalability using modular processes. The building includes a one-story section with utility yard and a three-story portion which includes adjacent green space and outdoor retention basins. Exterior site construction also included creating 318 outdoor parking spaces. The site has been submitted for LEED Gold certification.

To learn more about how the project is contributing to Philadelphia’s growing life sciences industry, check out the blog.